An Observational Study of Patients With Chronic Gastrointestinal Disease

NCT05774080 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2026-01-29

No results posted yet for this study

Summary

TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).

Conditions

  • Gastrointestinal Diseases

Interventions

OTHER

Observational

Observational

Sponsors & Collaborators

  • Target PharmaSolutions, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2037-12-31
Completion
2037-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05774080 on ClinicalTrials.gov